These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 21575383

  • 1. [Correlation between typing of peripheral neuroblastic tumors and prognosis: a clinicopathologic study of 135 cases].
    YIN MZ, ZHANG ZD, MA J, SHEN P, CHEN JF, ZHANG HZ.
    Zhonghua Bing Li Xue Za Zhi; 2011 Mar; 40(3):151-5. PubMed ID: 21575383
    [Abstract] [Full Text] [Related]

  • 2. [Clinicopathologic features of peripheral neuroblastic tumors].
    Yang BF, Fu LB, He LJ.
    Zhonghua Bing Li Xue Za Zhi; 2013 May; 42(5):305-10. PubMed ID: 24004586
    [Abstract] [Full Text] [Related]

  • 3. International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
    Shimada H, Umehara S, Monobe Y, Hachitanda Y, Nakagawa A, Goto S, Gerbing RB, Stram DO, Lukens JN, Matthay KK.
    Cancer; 2001 Nov 01; 92(9):2451-61. PubMed ID: 11745303
    [Abstract] [Full Text] [Related]

  • 4. Revision of the International Neuroblastoma Pathology Classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular.
    Peuchmaur M, d'Amore ES, Joshi VV, Hata J, Roald B, Dehner LP, Gerbing RB, Stram DO, Lukens JN, Matthay KK, Shimada H.
    Cancer; 2003 Nov 15; 98(10):2274-81. PubMed ID: 14601099
    [Abstract] [Full Text] [Related]

  • 5. The International Neuroblastoma Pathology Classification (the Shimada system).
    Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B, Stram DO, Gerbing RB, Lukens JN, Matthay KK, Castleberry RP.
    Cancer; 1999 Jul 15; 86(2):364-72. PubMed ID: 10421273
    [Abstract] [Full Text] [Related]

  • 6. [Peripheral neuroblastic tumors: anatomo pathological classification].
    Peuchmaur M.
    Ann Pathol; 2004 Dec 15; 24(6):556-67. PubMed ID: 15785402
    [Abstract] [Full Text] [Related]

  • 7. Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
    Goto S, Umehara S, Gerbing RB, Stram DO, Brodeur GM, Seeger RC, Lukens JN, Matthay KK, Shimada H.
    Cancer; 2001 Nov 15; 92(10):2699-708. PubMed ID: 11745206
    [Abstract] [Full Text] [Related]

  • 8. Prognostic value of International Neuroblastoma Pathology Classification in localized resectable peripheral neuroblastic tumors: a histopathologic study of localized neuroblastoma European Study Group 94.01 Trial and Protocol.
    Navarro S, Amann G, Beiske K, Cullinane CJ, d'Amore ES, Gambini C, Mosseri V, De Bernardi B, Michon J, Peuchmaur M, European Study Group 94.01 Trial and Protocol.
    J Clin Oncol; 2006 Feb 01; 24(4):695-9. PubMed ID: 16446343
    [Abstract] [Full Text] [Related]

  • 9. Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee.
    Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B.
    Cancer; 1999 Jul 15; 86(2):349-63. PubMed ID: 10421272
    [Abstract] [Full Text] [Related]

  • 10. TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
    Shimada H, Nakagawa A, Peters J, Wang H, Wakamatsu PK, Lukens JN, Matthay KK, Siegel SE, Seeger RC.
    Cancer; 2004 Oct 15; 101(8):1873-81. PubMed ID: 15386308
    [Abstract] [Full Text] [Related]

  • 11. [Pathology of peripheral neuroblastic tumors].
    Wang L, He LJ, Shimada H.
    Zhonghua Bing Li Xue Za Zhi; 2012 Apr 15; 41(4):283-8. PubMed ID: 22800533
    [No Abstract] [Full Text] [Related]

  • 12. International neuroblastoma pathology classification adds independent prognostic information beyond the prognostic contribution of age.
    Sano H, Bonadio J, Gerbing RB, London WB, Matthay KK, Lukens JN, Shimada H.
    Eur J Cancer; 2006 May 15; 42(8):1113-9. PubMed ID: 16624549
    [Abstract] [Full Text] [Related]

  • 13. Cytopathological spectrum of peripheral neuroblastic tumours in fine needle aspiration cytology and categorisation as per International Neuroblastoma Pathology Classification.
    Koshy A, Jain R, Srinivasan R, Bhatia P, Kakkar N, Rajwanshi A, Gupta N, Dey P, Trehan A, Bansal D.
    Cytopathology; 2019 Nov 15; 30(6):634-643. PubMed ID: 31231909
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. CD44s expression correlated with the International Neuroblastoma Pathology Classification (Shimada system) for neuroblastic tumours.
    Munchar MJ, Sharifah NA, Jamal R, Looi LM.
    Pathology; 2003 Apr 15; 35(2):125-9. PubMed ID: 12745459
    [Abstract] [Full Text] [Related]

  • 18. Surgical management and outcomes of ganglioneuroma and ganglioneuroblastoma-intermixed.
    Yang T, Huang Y, Xu T, Tan T, Yang J, Pan J, Hu C, Li J, Zou Y.
    Pediatr Surg Int; 2017 Sep 15; 33(9):955-959. PubMed ID: 28608056
    [Abstract] [Full Text] [Related]

  • 19. Extra-adrenal peripheral neuroblastic tumors: A clinicopathological study of 18 cases.
    Shankaralingappa S, Patra S, Gami A, Trivedi P, Chalaliya AK.
    Indian J Pathol Microbiol; 2023 Sep 15; 66(2):278-285. PubMed ID: 37077068
    [Abstract] [Full Text] [Related]

  • 20. Galectin-3 is a marker of favorable prognosis and a biologically relevant molecule in neuroblastic tumors.
    Veschi V, Petroni M, Bartolazzi A, Altavista P, Dominici C, Capalbo C, Boldrini R, Castellano A, McDowell HP, Pizer B, Frati L, Screpanti I, Gulino A, Giannini G.
    Cell Death Dis; 2014 Mar 06; 5(3):e1100. PubMed ID: 24603328
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.